Ad is loading...
JDIRX
Price
$44.91
Change
-$0.44 (-0.97%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

JDIRX vs VTSNX

Header iconJDIRX vs VTSNX Comparison
Open Charts JDIRX vs VTSNXBanner chart's image
Janus Henderson Overseas R
Price$44.91
Change-$0.44 (-0.97%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
JDIRX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDIRX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDIRX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. JDIRX (3.38B). VTSNX pays higher dividends than JDIRX: VTSNX (3.29) vs JDIRX (0.76). JDIRX was incepted earlier than VTSNX: JDIRX (15 years) vs VTSNX (14 years). JDIRX is a more actively managed with annual turnover of: 42.00 vs. VTSNX (4.00). JDIRX has a lower initial minimum investment than VTSNX: JDIRX (2500) vs VTSNX (5000000). JDIRX (11.11) and VTSNX (10.92) have marching annual gain over last year. JDIRX return over 5 years is better than : 43.58 vs. VTSNX (15.91).
JDIRXVTSNXJDIRX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years14 years-
Gain YTD4.2964.53595%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.38B442B1%
Annual Yield % from dividends0.763.2923%
Returns for 1 year11.1110.92102%
Returns for 3 years2.96-5.86-50%
Returns for 5 years43.5815.91274%
Returns for 10 years46.8129.81157%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals